Journal of Anesthesia

, Volume 24, Issue 2, pp 297–299

Involvement of the κ-opioid receptor in nitrous oxide-induced analgesia in mice

Short Communication

Abstract

Nitrous oxide (N2O)-induced analgesia is thought to be mediated by endogenous opioids. We previously showed that the μ-opioid receptor is not required for the analgesic action of N2O in mice using a gene knockout approach. In this study, we examined the effect of κ- (KOP)- or δ-opioid receptor (DOP)-selective antagonists on N2O-induced analgesia. The analgesic effect of N2O was evaluated using a writhing test. Male C57BL/6 mice aged 7–8 weeks were assigned to control, N2O, KOP agonist, and DOP agonist groups. According to the group assignment, mice were pretreated with a KOP antagonist, nor-binaltorphimine (nor-BNI), a DOP antagonist, naltrindole hydrochloride (NTI), a KOP agonist U50488, and a DOP agonist SNC80. Mice in the control, KOP agonist, and DOP agonist groups were exposed to 25% oxygen/75% nitrogen for 30 min, and mice in the N2O group were exposed to 25% oxygen/75% N2O for 30 min. Nor-BNI [10 mg kg–1, subcutaneously (s.c.)] significantly suppressed the analgesic effect of N2O and U50488. In contrast, NTI (10 mg kg–1 s.c.) did not significantly affect the analgesic action of N2O, but almost completely inhibited the analgesic effect of SNC80. These results suggest that KOP plays an important role in the analgesic effect of N2O in mice.

Keywords

Nitrous oxide Analgesia Opioid receptor 

References

  1. 1.
    Berkowitz B, Ngai S, Finck A. Nitrous oxide “analgesia”: resemblance to opiate action. Science. 1976;194:967–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25:167–89.CrossRefPubMedGoogle Scholar
  3. 3.
    Sanders R, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008;109:707–22.CrossRefPubMedGoogle Scholar
  4. 4.
    Emmanouil D, Dickens A, Heckert R, Ohgami Y, Chung E, Han S, Quock R. Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain. Eur Neuropsychopharmacol. 2008;18:194–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Koyama T, Mayahara T, Wakamatsu T, Sora I, Fukuda K. Deletion of μ-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth. 2009;103:744–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Portoghese P, Lipkowski A, Takemori A. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 1987;40:1287–92.CrossRefPubMedGoogle Scholar
  7. 7.
    Takemori A, Ho B, Naeseth J, Portoghese P. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther. 1988;246:255–8.PubMedGoogle Scholar
  8. 8.
    Portoghese P, Sultana M, Takemori A. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol. 1988;146:185–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Vonvoigtlander P, Lahti R, Ludens J. U-50, 488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther. 1983;224:7–12.PubMedGoogle Scholar
  10. 10.
    Bilsky E, Calderon S, Wang T, Bernstein R, Davis P, Hruby V, McNutt R, Rothman R, Rice K, Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther. 1995;273:359–66.PubMedGoogle Scholar
  11. 11.
    Quock R, Best J, Chen D, Vaughn L, Portoghese P, Takemori A. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur J Pharmacol. 1990;175:97–100.CrossRefPubMedGoogle Scholar
  12. 12.
    Branda E, Ramza J, Cahill F, Tseng L, Quock R. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 2000;65:217–21.CrossRefPubMedGoogle Scholar
  13. 13.
    Kingery W, Sawamura S, Agashe G, Davies M, Clark J, Zimmer A. Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide. Eur J Pharmacol. 2001;427:27–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Georgiev S, Kohno T, Ikoma M, Yamakura T, Baba H. Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons. Pain. 2008;134:24–31.CrossRefPubMedGoogle Scholar
  15. 15.
    Mueller J, Quock R. Contrasting influences of 5-hydroxytryptamine receptors in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 1992;41:429–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Mukaida K, Shichino T, Fukuda K. Nitrous oxide increases serotonin release in the rat spinal cord. J Anesth. 2007;21:433–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Yamakura T, Harris R. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology. 2000;93:1095–101.CrossRefPubMedGoogle Scholar
  18. 18.
    Gruss M, Bushell T, Bright D, Lieb W, Mathie A, Franks N. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65:443–52.CrossRefPubMedGoogle Scholar
  19. 19.
    Pan Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol Sci. 1998;19:94–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Fields H. State-dependent opioid control of pain. Nat Rev Neurosci. 2004;5:565–75.CrossRefPubMedGoogle Scholar
  21. 21.
    Santos M, Kuncar V, Martínez-Taboada F, Tendillo F. Large concentrations of nitrous oxide decrease the isoflurane minimum alveolar concentration sparing effect of morphine in the rat. Anesth Analg. 2005;100:404–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Endoh T, Matsuura H, Tanaka C, Nagase H. Nor-binaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther. 1992;316:30–42.PubMedGoogle Scholar
  23. 23.
    Ossipov M, Kovelowski C, Vanderah T, Porreca F. Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat. Neurosci Lett. 1994;181:9–12.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2010

Authors and Affiliations

  1. 1.Department of AnesthesiaKyoto University HospitalKyotoJapan

Personalised recommendations